(Q34188583)

31 July 2017

Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications (English)

1 reference

31 July 2017

Baldessarini RJ

1

1 reference

PubMed ID

11256650

31 July 2017

Tondo L

series ordinal

2

1 reference

PubMed ID

11256650

31 July 2017

Viguera AC

series ordinal

3

1 reference

31 July 2017

1 September 1999

1 reference

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

1

1 reference

31 July 2017

17-24

1 reference

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

31 July 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

Lithium discontinuation and subsequent effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

Pediatric-onset bipolar disorder: a neglected clinical and public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Long-term outcome and mortality of treated versus untreated bipolar and depressed patients: A preliminary report

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Does lithium treatment still work? Evidence of stable responses over three decades

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Discontinuation of maintenance treatment in bipolar disorder: risks and implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Effects of the Rate of Discontinuing Lithium Maintenance Treatment in Bipolar Disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Lithium prophylaxis of manic-depressive disorder: daily lithium dosing schedule versus every second day

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

A reevaluation of risk of in utero exposure to lithium

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Effect of lithium maintenance on suicidal behavior in major mood disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Lithium treatment and risk of suicidal behavior in bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

Discontinuing antidepressant treatment in major depression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.1999.10106.X

7 January 2021

10.1034/J.1399-5618.1999.10106.X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11256650